ANDERSONS INC/THE (ANDE) Fundamental Analysis & Valuation

NASDAQ:ANDE • US0341641035

Current stock price

66.44 USD
-2.12 (-3.09%)
At close:
65.96 USD
-0.48 (-0.72%)
After Hours:

This ANDE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ANDE Profitability Analysis

1.1 Basic Checks

  • ANDE had positive earnings in the past year.
  • ANDE had a positive operating cash flow in the past year.
  • Each year in the past 5 years ANDE has been profitable.
  • Of the past 5 years ANDE 4 years had a positive operating cash flow.
ANDE Yearly Net Income VS EBIT VS OCF VS FCFANDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of ANDE (2.58%) is worse than 60.53% of its industry peers.
  • ANDE has a Return On Equity of 7.69%. This is comparable to the rest of the industry: ANDE outperforms 42.11% of its industry peers.
  • The Return On Invested Capital of ANDE (4.78%) is comparable to the rest of the industry.
  • ANDE had an Average Return On Invested Capital over the past 3 years of 6.85%. This is significantly below the industry average of 29.49%.
Industry RankSector Rank
ROA 2.58%
ROE 7.69%
ROIC 4.78%
ROA(3y)2.66%
ROA(5y)2.62%
ROE(3y)7.97%
ROE(5y)8.91%
ROIC(3y)6.85%
ROIC(5y)6.77%
ANDE Yearly ROA, ROE, ROICANDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.87%, ANDE is doing worse than 60.53% of the companies in the same industry.
  • ANDE's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 1.17%, ANDE perfoms like the industry average, outperforming 42.11% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ANDE has declined.
  • ANDE has a worse Gross Margin (6.48%) than 89.47% of its industry peers.
  • ANDE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.17%
PM (TTM) 0.87%
GM 6.48%
OM growth 3Y-2.49%
OM growth 5YN/A
PM growth 3Y4.76%
PM growth 5Y54.36%
GM growth 3Y17.97%
GM growth 5Y7.39%
ANDE Yearly Profit, Operating, Gross MarginsANDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ANDE Health Analysis

2.1 Basic Checks

  • ANDE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ANDE has been reduced compared to 1 year ago.
  • The number of shares outstanding for ANDE has been increased compared to 5 years ago.
  • Compared to 1 year ago, ANDE has a worse debt to assets ratio.
ANDE Yearly Shares OutstandingANDE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ANDE Yearly Total Debt VS Total AssetsANDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 4.24 indicates that ANDE is not in any danger for bankruptcy at the moment.
  • ANDE has a Altman-Z score (4.24) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.65 indicates that ANDE is somewhat dependend on debt financing.
  • ANDE has a Debt to Equity ratio (0.65) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 4.24
ROIC/WACC0.73
WACC6.57%
ANDE Yearly LT Debt VS Equity VS FCFANDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • ANDE has a Current Ratio of 1.41. This is a normal value and indicates that ANDE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.41, ANDE is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
  • A Quick Ratio of 0.60 indicates that ANDE may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.60, ANDE perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.6
ANDE Yearly Current Assets VS Current LiabilitesANDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ANDE Growth Analysis

3.1 Past

  • ANDE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.86%.
  • ANDE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 109.65% yearly.
  • ANDE shows a decrease in Revenue. In the last year, the revenue decreased by -2.21%.
  • ANDE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.42% yearly.
EPS 1Y (TTM)-3.86%
EPS 3Y-7.17%
EPS 5Y109.65%
EPS Q2Q%50%
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-14.03%
Revenue growth 5Y6.42%
Sales Q2Q%-18.79%

3.2 Future

  • ANDE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.97% yearly.
  • ANDE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.00% yearly.
EPS Next Y50.59%
EPS Next 2Y32.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.5%
Revenue Next 2Y1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ANDE Yearly Revenue VS EstimatesANDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
ANDE Yearly EPS VS EstimatesANDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ANDE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.51 indicates a rather expensive valuation of ANDE.
  • ANDE's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of ANDE to the average of the S&P500 Index (25.23), we can say ANDE is valued inline with the index average.
  • ANDE is valuated correctly with a Price/Forward Earnings ratio of 13.62.
  • Based on the Price/Forward Earnings ratio, ANDE is valued a bit cheaper than the industry average as 76.32% of the companies are valued more expensively.
  • ANDE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.51
Fwd PE 13.62
ANDE Price Earnings VS Forward Price EarningsANDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ANDE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ANDE is cheaper than 60.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.65
ANDE Per share dataANDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ANDE's earnings are expected to grow with 32.97% in the coming years.
PEG (NY)0.41
PEG (5Y)0.19
EPS Next 2Y32.97%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ANDE Dividend Analysis

5.1 Amount

  • ANDE has a Yearly Dividend Yield of 1.17%.
  • ANDE's Dividend Yield is a higher than the industry average which is at 0.70.
  • Compared to the average S&P500 Dividend Yield of 1.89, ANDE is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

  • The dividend of ANDE has a limited annual growth rate of 2.85%.
  • ANDE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.85%
Div Incr Years0
Div Non Decr Years0
ANDE Yearly Dividends per shareANDE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 28.05% of the earnings are spent on dividend by ANDE. This is a low number and sustainable payout ratio.
  • The dividend of ANDE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.05%
EPS Next 2Y32.97%
EPS Next 3YN/A
ANDE Yearly Income VS Free CF VS DividendANDE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M
ANDE Dividend Payout.ANDE Dividend Payout, showing the Payout Ratio.ANDE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ANDE Fundamentals: All Metrics, Ratios and Statistics

ANDERSONS INC/THE

NASDAQ:ANDE (3/20/2026, 8:00:01 PM)

After market: 65.96 -0.48 (-0.72%)

66.44

-2.12 (-3.09%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners90.53%
Inst Owner Change6.05%
Ins Owners4.31%
Ins Owner Change4.81%
Market Cap2.26B
Revenue(TTM)11.01B
Net Income(TTM)95.71M
Analysts84.44
Price Target74.8 (12.58%)
Short Float %2.14%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Yearly Dividend0.79
Dividend Growth(5Y)2.85%
DP28.05%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-01
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)53.75%
Min EPS beat(2)28.48%
Max EPS beat(2)79.03%
EPS beat(4)3
Avg EPS beat(4)67.75%
Min EPS beat(4)-54.16%
Max EPS beat(4)217.65%
EPS beat(8)6
Avg EPS beat(8)69.27%
EPS beat(12)9
Avg EPS beat(12)48.4%
EPS beat(16)12
Avg EPS beat(16)49.22%
Revenue beat(2)0
Avg Revenue beat(2)-16.62%
Min Revenue beat(2)-24.22%
Max Revenue beat(2)-9.01%
Revenue beat(4)1
Avg Revenue beat(4)-8.43%
Min Revenue beat(4)-24.22%
Max Revenue beat(4)7.36%
Revenue beat(8)2
Avg Revenue beat(8)-8.72%
Revenue beat(12)2
Avg Revenue beat(12)-9.38%
Revenue beat(16)6
Avg Revenue beat(16)-1.44%
PT rev (1m)17.33%
PT rev (3m)37.5%
EPS NQ rev (1m)247.37%
EPS NQ rev (3m)247.37%
EPS NY rev (1m)8.59%
EPS NY rev (3m)12.42%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)-5.05%
Revenue NY rev (3m)-4.67%
Valuation
Industry RankSector Rank
PE 20.51
Fwd PE 13.62
P/S 0.21
P/FCF N/A
P/OCF 12.78
P/B 1.82
P/tB 2.15
EV/EBITDA 10.65
EPS(TTM)3.24
EY4.88%
EPS(NY)4.88
Fwd EY7.34%
FCF(TTM)-1.65
FCFYN/A
OCF(TTM)5.2
OCFY7.82%
SpS323.32
BVpS36.56
TBVpS30.94
PEG (NY)0.41
PEG (5Y)0.19
Graham Number51.62
Profitability
Industry RankSector Rank
ROA 2.58%
ROE 7.69%
ROCE 6.34%
ROIC 4.78%
ROICexc 4.99%
ROICexgc 5.47%
OM 1.17%
PM (TTM) 0.87%
GM 6.48%
FCFM N/A
ROA(3y)2.66%
ROA(5y)2.62%
ROE(3y)7.97%
ROE(5y)8.91%
ROIC(3y)6.85%
ROIC(5y)6.77%
ROICexc(3y)8.77%
ROICexc(5y)8.11%
ROICexgc(3y)9.9%
ROICexgc(5y)9.11%
ROCE(3y)8.57%
ROCE(5y)8.84%
ROICexgc growth 3Y-15.79%
ROICexgc growth 5YN/A
ROICexc growth 3Y-15.33%
ROICexc growth 5YN/A
OM growth 3Y-2.49%
OM growth 5YN/A
PM growth 3Y4.76%
PM growth 5Y54.36%
GM growth 3Y17.97%
GM growth 5Y7.39%
F-Score6
Asset Turnover2.97
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 3.09
Cap/Depr 174.86%
Cap/Sales 2.12%
Interest Coverage 2791.67
Cash Conversion 67.62%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.6
Altman-Z 4.24
F-Score6
WACC6.57%
ROIC/WACC0.73
Cap/Depr(3y)137.28%
Cap/Depr(5y)112.26%
Cap/Sales(3y)1.49%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.86%
EPS 3Y-7.17%
EPS 5Y109.65%
EPS Q2Q%50%
EPS Next Y50.59%
EPS Next 2Y32.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.21%
Revenue growth 3Y-14.03%
Revenue growth 5Y6.42%
Sales Q2Q%-18.79%
Revenue Next Year-1.5%
Revenue Next 2Y1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.75%
EBIT growth 3Y-16.17%
EBIT growth 5YN/A
EBIT Next Year356.73%
EBIT Next 3Y64.88%
EBIT Next 5YN/A
FCF growth 1Y-130.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3Y-14.89%
OCF growth 5YN/A

ANDERSONS INC/THE / ANDE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ANDERSONS INC/THE (ANDE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ANDE.


What is the valuation status for ANDE stock?

ChartMill assigns a valuation rating of 4 / 10 to ANDERSONS INC/THE (ANDE). This can be considered as Fairly Valued.


Can you provide the profitability details for ANDERSONS INC/THE?

ANDERSONS INC/THE (ANDE) has a profitability rating of 4 / 10.


What is the valuation of ANDERSONS INC/THE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ANDERSONS INC/THE (ANDE) is 20.51 and the Price/Book (PB) ratio is 1.82.


How financially healthy is ANDERSONS INC/THE?

The financial health rating of ANDERSONS INC/THE (ANDE) is 4 / 10.